Original Article

Comparison of Two Forms of Albuterol for Treatment of Acute Bronchospasm in Pediatric Patients

Background The Circulaire nebulizer (C-Neb) is marketed as superior to low-dose albuterol for acute bronchospasm. Methods This clinical trial design compared clinical and fiscal outcomes of patients treated with C-Neb and high-dose albuterol (HDA). Eligibility criteria included reactive airway disease, age >5 years, and asthma score (AS) of 2 to…